IL6 and type 2 diabetes mellitus: Our results suggest that circulating blood monocytes in vivo may respond to increases in saturated NEFA concentrations in insulin resistant conditions by producing high levels of IL-6, which could prime these cells to generate a robust local or systemic inflammatory response and contribute to the development of complications such as T2DM and atherosclerosis.